3 options
Therapeutic Strategies in Lipid Disorders [electronic resource].
- Format:
- Book
- Author/Creator:
- Tonkin, AM.
- Series:
- Therapeutic Strategies
- Language:
- English
- Subjects (All):
- Lipids--Metabolism--Disorders.
- Lipids--Metabolism.
- Medicine.
- Local Subjects:
- Lipids--Metabolism--Disorders.
- Lipids--Metabolism.
- Medicine.
- Physical Description:
- 1 online resource (282 p.)
- Place of Publication:
- Oxford : Atlas Medical Publishing Ltd, 2009.
- Language Note:
- English
- Summary:
- Lipid disorders are now recognised as a diverse group of diseases that together represent one of the foremost risk factors for cardiovascular disease in general. Frequently present in association with other chronic illnesses such as hypertension, diabetes, and obesity, lipid disorders are a key therapeutic target for clinicians.This book examines the causes and consequences of lipid disorders, and the treatments available. Special chapters are dedicated to the associations between lipid disorders and other conditions, for example cerebrovascular disease and heart failure, as well as the wider
- Contents:
- Contents; Editorand Contributors; Foreword; Chapter 1: A global view of cardiovascular risk factors; Chapter 2: Low-density lipoprotein cholesterol as a therapeutic target; Chapter 3: High-density lipoprotein as a therapeutic target; Chapter 4: Apolipoprotein B in the therapy of atherogenic dyslipoproteinaemias; Chapter 5: Management of coronary heart disease patients; Chapter 6: Stroke and transient ischaemic attack prevention; Chapter 7: Diabetes and the metabolic syndrome; Chapter 8: Hypertension; Chapter 9: Treatment of familial hypercholesterolaemia
- Chapter 10: Lipid lowering in chronic kidney diseaseChapter 11: Statins and heart failure; Chapter 12: Absolute risk assessment in the general population; Chapter 13: Pleiotropic effects of statins and potential new indications; Chapter 14: The role of imaging endpoints in clinical trials; Chapter 15: Biomarkers in cardiovascular disease; Chapter 16: Novel lipid-modifying agents; Chapter 17: The enhanced evidence base and translation into improved outcomes; Abbreviations; Index
- Notes:
- Description based upon print version of record.
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 1-282-09391-6
- 9786612093913
- 1-84692-601-7
- OCLC:
- 666931928
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.